This was further confirmed by the activation of NF-κB family members in IBN-R cells compared with IBN-S cells (Supplemental Figure 1H), suggesting upregulated NF-κB signaling associated with poor MCL patient survival. The gene discussed is NFKB1; the disease is mantle cell lymphoma.